Insecticides India Ltd Downgraded to Strong Sell Amid Weak Financials and Mixed Valuation

Quality Assessment: Persistent Weakness in Financial Performance

Insecticides India Ltd’s quality rating remains under pressure due to its recent financial performance. The company has reported negative results for three consecutive quarters, with the latest Q1 FY26-27 figures showing a 27.47% decline in Profit Before Tax (excluding other income) to ₹53.48 crores and a 24.5% drop in Profit After Tax to ₹43.87 crores. Net sales also contracted by 11.52% to ₹611.52 crores in the same quarter.

Long-term growth metrics further highlight the challenges faced by the company. Over the past five years, net sales have grown at a modest compound annual growth rate (CAGR) of 6.86%, while operating profit has increased by only 5.83% annually. This sluggish growth trajectory contrasts unfavourably with sector peers and broader market indices.

Moreover, the stock has delivered a negative return of 26.17% over the last year, significantly underperforming the Sensex’s 3.57% decline and the BSE500 index over multiple time frames. Although the company has maintained a low average debt-to-equity ratio of 0.05 times, its return on equity (ROE) of 12.17% and return on capital employed (ROCE) of 16.04% have not been sufficient to offset the broader financial weaknesses.

Valuation Upgrade: From Very Attractive to Attractive

Contrasting with the deteriorating financial trend, Insecticides India Ltd’s valuation grade has improved from very attractive to attractive. The company currently trades at a price-to-earnings (PE) ratio of 14.21, which is considerably lower than several peers such as Bayer CropScience (PE 24.51) and BASF India (PE 26.23). Its enterprise value to EBITDA (EV/EBITDA) multiple stands at 8.66, also below the sector average, indicating relatively reasonable pricing.

Other valuation metrics reinforce this assessment: the price-to-book value ratio is 1.46, and the enterprise value to sales ratio is 0.88, both suggesting the stock is trading at fair value compared to its historical and peer benchmarks. The company’s PEG ratio remains at 0.00, reflecting a lack of expected earnings growth, which tempers the valuation optimism.

Dividend yield is modest at 0.33%, which may not be a significant draw for income-focused investors but aligns with the company’s cautious financial outlook.

Financial Trend: Negative Momentum Persists

The financial trend for Insecticides India Ltd remains negative, with the company’s quarterly results signalling ongoing operational challenges. The decline in profitability and sales over recent quarters has eroded investor confidence, reflected in the stock’s underperformance relative to the Sensex and sector indices.

Despite a small-cap market capitalisation and a stable promoter holding, the company’s earnings trajectory has been disappointing. The 1-year return of -26.17% starkly contrasts with the Sensex’s -3.57%, while the 3-year return of 24.72% lags behind the Sensex’s 18.70% gain, indicating some recovery over a longer horizon but insufficient to offset recent setbacks.

Operating profit growth of 5.83% over five years is below expectations for a company in the pesticides and agrochemicals sector, where innovation and market expansion are critical. The negative quarterly trends suggest that these growth drivers have not materialised effectively for Insecticides India Ltd.

Technicals: Weak Signals Amid Price Volatility

Technically, the stock has shown volatility with a day change of +2.23% on 1 September 2026, closing at ₹611.05, slightly above the previous close of ₹597.75. The 52-week price range spans from ₹525.90 to ₹833.30, indicating significant price fluctuations over the year.

However, the stock’s recent price action has not translated into a sustained uptrend. The Mojo Grade downgrade from Sell to Strong Sell reflects weak technical indicators, including underperformance against sector peers and broader market indices. The stock’s relative strength remains subdued, and momentum indicators suggest caution for short-term investors.

Given the company’s financial and operational challenges, technical analysis supports a bearish outlook, reinforcing the downgrade decision.

Comparative Industry Context and Peer Analysis

Within the pesticides and agrochemicals sector, Insecticides India Ltd’s valuation metrics are relatively attractive. For instance, Bayer CropScience trades at a PE of 24.51 and an EV/EBITDA of 18.44, while BASF India’s PE stands at 26.23 with an EV/EBITDA of 16.61. Insecticides India’s PE of 14.21 and EV/EBITDA of 8.66 position it favourably on a valuation basis.

However, peers such as Sharda Cropchem and Dhanuka Agritech offer even more compelling valuations, with Sharda Cropchem’s PE at 11.09 and EV/EBITDA at 6.08, and Dhanuka Agritech’s PE at 14.63 and EV/EBITDA at 10.31. These companies also demonstrate stronger growth prospects and more robust financial trends, which may explain their higher investor appeal.

Insecticides India’s PEG ratio of 0.00 indicates a lack of expected earnings growth, contrasting with peers like Bayer CropScience (PEG 1.04) and BASF India (PEG 0.52), which suggests that the market anticipates limited expansion in profitability for Insecticides India.

Outlook and Investor Considerations

While the valuation upgrade to attractive may tempt value investors, the persistent negative financial trends and weak technical signals warrant caution. The company’s inability to generate consistent growth in sales and profits, coupled with recent quarterly declines, undermines confidence in a near-term turnaround.

Investors should weigh the company’s reasonable valuation against its operational challenges and sector dynamics. The stock’s underperformance relative to the Sensex and BSE500 indices over multiple time frames highlights the risks involved.

Given these factors, the downgrade to a Strong Sell rating reflects a prudent stance, signalling that the stock may continue to face headwinds unless there is a marked improvement in financial performance and market sentiment.

Summary of Ratings and Scores

As of 31 August 2026, Insecticides India Ltd holds a Mojo Score of 28.0 with a Mojo Grade of Strong Sell, downgraded from Sell. The valuation grade has improved from very attractive to attractive, but quality, financial trend, and technical grades have deteriorated, driving the overall negative outlook.

The company remains classified as a small-cap stock within the pesticides and agrochemicals sector, with promoters holding the majority stake. Investors should monitor quarterly results closely for signs of recovery before considering exposure.

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today